Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microfibrillar-associated protein 4 (MFAP4) is an extracellular matrix glycoprotein primarily associated with elastic fibers and is involved in cell adhesion and intercellular interactions (UniProt P55083). The 3' untranslated region (UTR) of the MFAP4 mRNA serves as a critical regulatory hub, containing specific binding sites for microRNAs and RNA-binding proteins that dictate the stability and translation efficiency of the transcript. In pathological states such as liver fibrosis and cirrhosis, MFAP4 is significantly upregulated, where it promotes the activation of hepatic stellate cells and contributes to excessive collagen deposition (PubMed: 26861755). Research has demonstrated that microRNAs like miR-145-5p directly target the MFAP4 mRNA 3' UTR to suppress its expression, suggesting that this region is a viable therapeutic target for RNA-based interventions (PubMed: 31431358). Therapeutic strategies targeting this 3' UTR, such as microRNA mimics or antisense oligonucleotides, aim to reduce MFAP4 protein levels to mitigate tissue remodeling and fibrotic progression. Additionally, MFAP4 has been identified as a robust serum biomarker for monitoring the stage of liver fibrosis in clinical settings (PubMed: 24535641). Understanding the regulatory landscape of the MFAP4 3' UTR is essential for developing precision therapies for chronic fibroproliferative diseases and certain cancers.
Post-transcriptional gene silencing via RNA interference or steric hindrance of the 3' untranslated region to prevent protein translation or induce mRNA degradation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microfibrillar-associated protein 4 mRNA 3' untranslated region (MFAP4 mRNA 3' UTR).